This HTML5 document contains 42 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n11http://linked.opendata.cz/resource/drugbank/drug/DB03088/identifier/pubchem-compound/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03088/identifier/pubchem-substance/
n6http://linked.opendata.cz/resource/drugbank/drug/DB03088/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n15http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03088/identifier/chebi/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB03088/identifier/pdb/
n7http://linked.opendata.cz/resource/drugbank/drug/DB03088/identifier/kegg-compound/

Statements

Subject Item
n2:DB03088
rdf:type
n3:Drug
n3:description
A cyclized derivative of L-GLUTAMIC ACID. Elevated blood levels may be associated with problems of GLUTAMINE or GLUTATHIONE metabolism. [PubChem]
n3:group
experimental
owl:sameAs
n13:DB03088 n15:DB03088
dcterms:title
Pyroglutamic Acid
adms:identifier
n6:DB03088 n7:C01879 n8:18183 n9:46506886 n10:5HP n11:439685
n3:synthesisReference
John G. Black, Ian R. Scott, "Pyroglutamic acid esters, their synthesis and use in topical products." U.S. Patent US4774255, issued December, 1974.
n3:IUPAC-Name
n4:271B4DF8-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4DFE-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4DFD-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4DFA-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4DFB-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4DFC-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4DF6-363D-11E5-9242-09173F13E4C5 n4:271B4E0E-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4DF7-363D-11E5-9242-09173F13E4C5 n4:271B4DF4-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4DF5-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4E04-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4E05-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4DFF-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4E00-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4E02-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4E01-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4E03-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
98-79-3
n3:Bioavailability
n4:271B4E0A-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4E0C-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4E0D-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B4E0F-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4E09-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4E08-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4E0B-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4DF9-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4E06-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4E07-363D-11E5-9242-09173F13E4C5